Health Technology · Pharmaceuticals: Major · NSE: INDSWFTLAB · data 2026-10-09

Ind-Swift Laboratories Ltd.

Health check: Average (5.1/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹360.9

Market cap

₹3,191 cr

P/E

53.9

P/B

—

ROE

3.4%

ROCE

-0.2%

Debt / equity

0.01

Dividend yield

0.00%

1-year return

257.3%

52-week high

₹424.75

52-week low

₹87.15

Operating margin

4.2%

Growth

Revenue (last 12 months)	₹665 cr
Net profit (last 12 months)	₹57 cr
Sales growth, 3 years (yearly)	-19.6%
Profit growth, 3 years (yearly)	-3.2%

Similar companies

Aarti Drugs Limited (AARTIDRUGS) · Unichem Laboratories Limited (UNICHEMLAB) · Kwality Pharmaceuticals Ltd (KPL) · Solara Active Pharma Sciences Ltd. (SOLARA) · Shukra Pharmaceuticals Ltd. (SHUKRAPHAR)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INDSWFTLAB in NSE Scanner →